|
WO2019126166A1
|
|
Transdermal pharmaceutical compositions with reduced skin irritation
|
|
US2018185440A1
|
|
Pharmaceutical compositions and methods for delivery of bremelanotide
|
|
US2018036319A1
|
|
Transdermal drug delivery systems for norethindrone acetate
|
|
EP3506889A1
|
|
Pressure-sensitive adhesives for transdermal drug delivery
|
|
US2017189363A1
|
|
Gastric acid modulators for oral delivery of peptides and proteins
|
|
US2017136124A1
|
|
Stretchable backing layers for transdermal drug delivery systems
|
|
US2017112781A1
|
|
Transdermal drug delivery systems with polyisobutylene face adhesive
|
|
US2017100481A1
|
|
Transdermal pharmaceutical compositions with reduced skin irritation
|
|
US2016374954A1
|
|
Pressure-sensitive adhesives for transdermal drug delivery
|
|
WO2017004507A1
|
|
Transdermal drug delivery systems for levonorgestrel and ethinyl estradiol
|
|
MX2017011349A
|
|
Oligomeric/polymeric silicone fluids for use in transdermal drug delivery systems.
|
|
CN107532050A
|
|
Contact adhesive for cutaneous penetration
|
|
WO2016109483A1
|
|
Transdermal drug delivery systems for agomelatine
|
|
US9987361B1
|
|
Compositions and method for sustained drug delivery by active transdermal technology
|
|
US2016045720A1
|
|
Microneedle device and methods
|
|
EP3179989A1
|
|
Silicone-containing acrylic polymers for transdermal drug delivery compositions
|
|
MX2016008207A
|
|
Compositions and methods for transdermal delivery of amphetamine.
|
|
WO2014151387A1
|
|
Stable transdermal amphetamine compositions and methods of manufacture
|
|
US2014276483A1
|
|
Transdermal methylphenidate compositions with acrylic block copolymers
|
|
US2014276479A1
|
|
Transdermal drug delivery system with overlay
|
